Kehua Bio-Engineering reports Q3 2025 convertible bond activity

During the third quarter of 2025, Shanghai Kehua Bio-Engineering's convertible bonds saw a reduction of CNY 615,000 (6,150 bonds) due to conversions, resulting in the issuance of 29,785 new shares. Additionally, CNY 7,000 (70 bonds) of convertible bonds were reduced due to bondholder putbacks. As of September 30, 2025, the remaining balance of convertible bonds stood at CNY 224,584,100 (2,245,841 bonds).

The company's total share capital increased by 29,785 shares to 514,348,244 shares. Concurrently, the number of unrestricted tradable shares rose to 514,250,744 shares, while restricted tradable shares, specifically those under high-level management lock-up, increased to 97,500 shares. The current turn price for the convertible bonds is CNY 20.64 per share, valid until July 27, 2026.

This information is based on the company's announcement dated October 10, 2025.